Obstetric and neonatal outcomes of cancer treated during pregnancy

Janelle R. Walton, Mona R. Prasad*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Cancer diagnosed during pregnancy is a rare occurrence with an incidence of 0.1% of all pregnancies. However, its management can be challenging at times as one balances maternal benefit to fetal risk. Various treatment modalities are used in this context including surgical intervention, chemotherapy, and radiologic therapy. This review seeks to address the impact of pregnancy on disease as well as the effect of malignancy and its treatment on both mother and fetus. Attention is focused on the more common malignancies associated with pregnancy: cervix, breast, melanoma, and hematologic malignancies. In addition, special emphasis is placed on timing of delivery and how that affects neonatal outcomes.

Original languageEnglish (US)
Pages (from-to)567-573
Number of pages7
JournalClinical Obstetrics and Gynecology
Issue number4
StatePublished - Dec 1 2011


  • cancer
  • malignancy
  • pregnancy
  • treatment

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Obstetric and neonatal outcomes of cancer treated during pregnancy'. Together they form a unique fingerprint.

Cite this